Clinical Trial Data on Cocaine Use via Quantitative Urinalysis

Clinical trial data for monitoring cocaine use, likely collected by the National Institute on Drug Abuse. The description focuses on the use of urinalysis as a primary outcome measure, specifically testing for the metabolite benzoylecgonine with a standard cutoff of 300 ng/mL. The dataset appears to be associated with research by author Kenzie L. Preston.

Use Cases

• Evaluating the sensitivity of treatment outcome measures based on urinalysis data mentioned in the description
• Analyzing patterns of cocaine use in clinical trial settings based on qualitative immunoassay results
• Modeling the relationship between treatment types and cocaine metabolite levels based on the described clinical trial context

Strengths

• Description specifies a concrete measurement standard: a 300 ng/mL cutoff for benzoylecgonine detection.
• The dataset is associated with a specific author and the National Institute on Drug Abuse, suggesting a credible research context.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

National Institute on Drug Abuse

Collection Method

Likely collected from clinical trials evaluating cocaine abuse treatments, as described.